St. John's Wort Extract LI 160 for the Treatment of Atypical Depression
Phase 3
Completed
- Conditions
- Atypical Depression
- Interventions
- Drug: PlaceboDrug: St. John's Wort extract
- First Posted Date
- 2009-03-16
- Last Posted Date
- 2009-03-16
- Lead Sponsor
- Cassella-med GmbH & Co. KG
- Target Recruit Count
- 201
- Registration Number
- NCT00861978
© Copyright 2025. All Rights Reserved by MedPath